[1]常 双,殷晓明,殷兰芳,等.FRAX联合血清学指标评估老年T2DM患者骨质疏松风险的研究[J].医学信息,2022,35(16):76-78.[doi:10.3969/j.issn.1006-1959.2022.16.017]
　CHANG Shuang,YIN Xiao-ming,YIN Lan-fang,et al.Evaluation of Osteoporosis Risk in Elderly Patients with T2DM by FRAX Combined with Serological Markers[J].Journal of Medical Information,2022,35(16):76-78.[doi:10.3969/j.issn.1006-1959.2022.16.017]
点击复制

FRAX联合血清学指标评估老年T2DM患者骨质疏松风险的研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年16期
页码:
76-78
栏目:
论著
出版日期:
2022-08-15

文章信息/Info

Title:
Evaluation of Osteoporosis Risk in Elderly Patients with T2DM by FRAX Combined with Serological Markers
文章编号:
1006-1959（2022）16-0076-03
作者:
常 双; 殷晓明; 殷兰芳; 等
（安徽医科大学附属安庆医院全科1，老年病科2，安徽 安庆 246004）
Author(s):
CHANG Shuang; YIN Xiao-ming; YIN Lan-fang; et al.
(Department of General Practice1,Department of Geriatrics2,Anqing Hospital Affiliated to Anhui Medical University,Anqing 246004,Anhui,Cina)
关键词:
2型糖尿病; 骨质疏松; 碱性磷酸酶; 骨密度; FRAX骨折风险评分
Keywords:
Type 2 diabetes mellitus; Osteoporosis; Alkaline phosphatase; Bone density; FRAX fracture risk score
分类号:
R580；R587.1
DOI:
10.3969/j.issn.1006-1959.2022.16.017
文献标志码:
A
摘要:
目的 探讨老年2型糖尿病（T2DM）患者的血清学指标、骨密度及FRAX骨折风险评分的变化与骨质疏松之间的关系。方法 选择2020年6月-2021年1月在我院就诊的老年T2DM患者68例作为观察组，另选同期健康人48名作为对照组，比较两组血清学指标、骨密度水平，采用骨折危险评估工具计算髋部骨折风险及主要骨质疏松率，分析T2DM合并骨质疏松的临床特征。结果 观察组血糖、碱性磷酸酶、血钙、血磷水平均高于对照组，骨密度低于对照组，差异有统计学意义（P＜0.05）；相关性分析显示，T2DM患者骨密度与血清钙、磷水平呈正相关（r=0.379、0.047，P＜0.05），与碱性磷酸酶呈负相关（r=-0.523，P＜0.05）；ROC生存曲线显示，髋部骨折风险、主要骨质疏松率对T2DM患者骨折风险的评估具有早期识别作用。结论 FRAX骨折风险评分联合血清学指标可较准确的筛查出高骨质疏松风险的老年糖尿病患者，该法有助于临床及时对患者进行干预，改善其预后。
Abstract:
Objective To investigate the relationship between the changes of serum markers, bone mineral density and FRAX fracture risk score in elderly patients with type 2 diabetes mellitus(T2DM) and osteoporosis.Methods A total of 68 elderly patients with T2DM who were treated in our hospital from June 2020 to January 2021 were selected as the observation group, and 48 healthy people in the same period were selected as the control group. The serological indexes and bone mineral density levels of the two groups were compared. The fracture risk assessment tool was used to calculate the risk of hip fracture and the main osteoporosis rate, and the clinical characteristics of T2DM combined with osteoporosis were analyzed.Results The levels of blood glucose, alkaline phosphatase, serum calcium and serum phosphorus in the observation group were higher than those in the control group, and the bone mineral density was lower than that in the control group (P<0.05). Correlation analysis showed that bone mineral density was positively correlated with serum calcium and phosphorus levels (r=0.379, 0.047, P<0.05), and negatively correlated with alkaline phosphatase (r=-0.523, P<0.05). The ROC survival curve showed that hip fracture risk and major osteoporosis rate had early identification effect on fracture risk assessment in T2DM patients.Conclusion FRAX fracture risk score combined with serological indicators can accurately screen out elderly diabetic patients with high risk of osteoporosis. This method is helpful for timely clinical intervention and improvement of prognosis.

参考文献/References:

[1]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.[2]王毅.甲状旁腺激素和25羟维生素D对2型糖尿病患者并发骨质疏松症的影响[J].安徽医药,2018,22(10):1901-1904.[3]蒋晓南,李全忠.2型糖尿病患者血糖波动与骨代谢指标及骨密度的关系[J].山东医药,2021,61(13):17-20,24.[4]Shayganfar A,Ebrahimian S,Masjedi M,et al.A study on bone mass density using dual energy X-ray absorptiometry:Does high body mass index have protective effect on bone density in obese patients?[J].J Res Med Sci,2020,25:4.[5]李定中,乐云敏,顾晓东,等.阿法骨化醇软胶囊治疗2型糖尿病骨质疏松的疗效观察[J].中国药物与临床,2019,19(21):3746-3748.[6]陈芳.碳酸钙D3片联合阿法骨化醇软胶囊治疗2型糖尿病合并骨质疏松的效果观察[J].临床合理用药杂志,2019,12(25):61-62.[7]周婷婷,冯正平.绝经后女性2型糖尿病伴骨质疏松患者骨密度与骨代谢指标的相关性分析[J].中国骨质疏松杂志,2019,25(1):29-32.[8]丁霏,陈彦丽,廖静,等.甲状旁腺素、25-羟维生素D及血清钙磷与原发性骨质疏松症的相关性分析[J].国际检验医学杂志,2020,41(6):648-651.[9]朱静,李娜.血清骨特异性碱性磷酸酶骨钙素甲状旁腺激素抗酒石酸酸性磷酸酶5b检测对老年女性骨质疏松症的诊断分析[J].山西医药杂志,2020,49(15):1993-1995.[10]中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.[11]Russow G,Jahn D,Appelt J,et al.Anabolic Therapies in Osteoporosis and Bone Regeneration[J].International Journal of Molecular Sciences,2018,20(1):83.[12]Jaalkhorol M,Fujita Y,Kouda K,et al.Low bone mineral density is associated with an elevated risk of developing increased arterial stiffness: A 10-year follow-up of Japanese women from the Japanese Population-based Osteoporosis (JPOS) cohort study[J].Maturitas,2019,119:39-45.[13]Chen Z,Bemben MG,Bemben DA.Bone and muscle specific circulating microRNAs in postmenopausal women based on osteoporosis and sarcopenia status[J].Bone,2019,120:271-278.[14]杨梅,沈红宇,沈建新,等.40岁以上人群骨密度与血清钙磷代谢、维生素D及骨代谢的相关性研究[J].东南大学学报(医学版),2021,40(1):22-26.[15]Lai EL,Huang WN,Chen HH,et al.Ten-year fracture risk by FRAX and osteoporotic fractures in patients with systemic autoimmune diseases[J].Lupus,2019,28(8):945-953.

相似文献/References:

[1]王 忻,赵 毅,朱 悦,等.甲状旁腺激素应用于大鼠脊髓损伤后防治骨质疏松的效果分析[J].医学信息,2018,31(02):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
　WANG Xin,ZHAO Yi,ZHU Yue,et al.Effect of Parathyroid Hormone on Prevention and Treatment of Osteoporosis after Spinal Cord Injury in Rats[J].Journal of Medical Information,2018,31(16):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
[2]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(16):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[3]吴玲,李玉兰.个性化心理护理干预应用于骨质疏松的临床效果观察[J].医学信息,2018,31(01):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
　WU Ling,LI Yu-lan.The Clinical Effect of Personalized Psychological Nursing Intervention on Osteoporosis[J].Journal of Medical Information,2018,31(16):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
[4]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(16):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[5]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(16):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[6]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(16):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[7]刘小花.经皮穿刺椎体成形术治疗老年性骨质疏松性 椎体压缩骨折的疗效分析[J].医学信息,2018,31(05):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
　LIU Xiao-hua.The Effect of Percutaneous Vertebroplasty in the Treatment of Senile Osteoporotic Vertebral Compression Fracture[J].Journal of Medical Information,2018,31(16):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
[8]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(16):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[9]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(16):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[10]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(16):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]

更新日期/Last Update: 1900-01-01